Belgian scientists from VIB and Ghent University (UGent), together with Danish collaborators, have uncovered compelling ...

A pooled multicountry analysis shows that immunisation with nirsevimab effectively reduced RSV-related hospitalisation in ...

After a Type C discussion, Blue Lake got the FDA nod to enrol both RSV-positive and negative children above the age of 18 ...

When it comes to RSV season, we’re not out of the woods quite yet. We may now be beyond the peak of RSV cases, but that doesn’t mean that the respiratory virus isn’t still circulating at a high rate ...

The RSV shot isn't suggested for everyone like the flu vaccine is. Here's who is at risk and how to get a shot.

The preventive effects of nirsevimab against respiratory syncytial virus infection persisted for up to 12 months after ...

Researchers found differences in how respiratory syncytial virus spreads among children in rural versus urban communities and ...

This fall and winter, children will be susceptible to COVID-19, the flu, RSV and colds. Many of the symptoms for all four viruses overlap, which makes it difficult to determine which illness your ...

Share on Pinterest A recent study suggests that RSV can directly infect nerve cells, potentially causing neurological symptoms in young children. Maskot/Getty Images Respiratory syncytial virus (RSV) ...

A common seasonal virus that can cause serious illness in infants is spreading among children earlier and faster this year: Cases of respiratory syncytial virus, better known as RSV, are on the rise, ...